Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Design and Evaluation of a Novel Methodology for Stereotactic Ablative Radiotherapy for Lung Cancer: Reducing Treatment Side-effects and Enabling More Patients to Benefit From This Treatment

NCT04928755 is registered in ClinicalTrials.gov with Royal Surrey County Hospital NHS Foundation Trust as lead sponsor.

NCT NCT04928755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04928755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Design and Evaluation of a Novel Methodology for Stereotactic Ablative Radiotherapy for Lung Cancer: Reducing Treatment Side-effects and Enabling More Patients to Benefit From This Treatment
Lead sponsor
Royal Surrey County Hospital NHS Foundation Trust
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2021
Completion date
December 31, 2023
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer